Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Endocrinology | Family Medicine
Disease Category: Diabetes Mellitus, Type 2
Location: United States, FL

Clinical Trial Details

Overview

Research Study Summary

A 22-week research study is evaluating if a new investigational insulin can provide effective and consistent blood sugar control in people with type 2 diabetes.

Purpose

You may qualify if you:

  • Are 18 years of age or older
  • Have taken insulin for at least 12 weeks
  • Have had a diagnosis of type 2 diabetes for at least 24 weeks
  • Have taken an unchanged dose of Oral Antidiabetic Drugs (OAD) for at least 12 weeks
  • Have an HbA1c level between 7.0-10.0%
  • Have a BMI of 45 kg/m2 or less

Contact us for more information:www.metabolic-institute.com/information.htm

To Learn more
Gender

Both Male and Female

Age

18 and up

Overall Status

Recruiting

Duration

22 Weeks

Facility Type

N/A

Contact

Rochelle Dobson
Metabolic Research Institute, Inc.
1515 N. Flagler Dr., Ste 440
West Palm Beach, FL 33401
Phone: 561-802-3060
Fax: 561-802-3260

View Map

Research Center Information: Metabolic Research Institute, Inc.

CW ID: 176682

Date Last Changed: July 22, 2013


DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.